Scientists test drug mix safety in healthy volunteers
NCT ID NCT06494761
Summary
This early-stage study aimed to understand how taking multiple doses of an experimental cancer drug, zongertinib, might change how the body processes three other common medications (midazolam, omeprazole, and repaglinide). It involved 16 healthy male volunteers who took the drugs in a specific sequence over two periods. The goal was to gather safety data to inform future use in cancer patients who often take multiple medications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany
Conditions
Explore the condition pages connected to this study.